Regulation of cytokine expression and leukotriene formation in human basophils by growth factors, chemokines and chemotactic agonists
- PMID: 9933081
- DOI: 10.1002/(SICI)1521-4141(199901)29:01<11::AID-IMMU11>3.0.CO;2-B
Regulation of cytokine expression and leukotriene formation in human basophils by growth factors, chemokines and chemotactic agonists
Abstract
Basophils stimulated with IL-3 plus C5a selectively express IL-4 and IL-13 and continuously produce leukotrienes (LT) for hours. C5a combined with IL-5 or granulocyte-macrophage colony-stimulated factor was, however, much less effective in promoting cytokine expression and a late continuous phase of LTC4 production, possibly due to lower expression levels of their receptor alpha chains. Basophils also express several chemoattractant receptors, including high levels of C5a receptors, macrophage chemotactic protein (MCP) receptors (CCR2) and eotaxin receptors (CCR3), intermediate levels of CXCR1, CXCR2 and platelet-activating factor receptors, and lower levels of N-formyl-Met-Leu-Phe (fMLP) receptors. However, among the corresponding agonists, only C5a, fMLP and much more weakly MCP1, were found to induce cytokine expression and continuous LTC4 release, and only when combined with IL-3. CCR3, which is highly expressed on basophils and has been shown to mediate strong migratory but weak release responses, does not regulate cytokine expression. The weakly expressed fMLP receptor is an efficient activator of several cell functions including LTC4 formation, while CXCR2 hardly affects basophil function despite considerable expression. Thus, chemoattractant-receptors mediate different cellular responses unrelated to their expression levels.
Similar articles
-
Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.J Allergy Clin Immunol. 1996 Jul;98(1):152-64. doi: 10.1016/s0091-6749(96)70237-3. J Allergy Clin Immunol. 1996. PMID: 8765829
-
IgE-independent interleukin-4 expression and induction of a late phase of leukotriene C4 formation in human blood basophils.Blood. 1995 Dec 1;86(11):4039-49. Blood. 1995. PMID: 7492759
-
Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5.J Immunol. 1991 Jul 1;147(1):237-42. J Immunol. 1991. PMID: 1711077
-
The role of basophils in allergic disease.Eur Respir J Suppl. 1996 Aug;22:126s-131s. Eur Respir J Suppl. 1996. PMID: 8871057 Review.
-
The structural and functional basis of cytokine receptor activation: lessons from the common beta subunit of the granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 receptors.Blood. 1997 Mar 1;89(5):1471-82. Blood. 1997. PMID: 9057626 Review. No abstract available.
Cited by
-
Basophils beyond allergic and parasitic diseases.Front Immunol. 2023 May 2;14:1190034. doi: 10.3389/fimmu.2023.1190034. eCollection 2023. Front Immunol. 2023. PMID: 37205111 Free PMC article. Review.
-
Behind the scenes with basophils: an emerging therapeutic target.Immunother Adv. 2021 May 19;1(1):ltab008. doi: 10.1093/immadv/ltab008. eCollection 2021 Jan. Immunother Adv. 2021. PMID: 35919744 Free PMC article. Review.
-
Differential Effects of Alarmins on Human and Mouse Basophils.Front Immunol. 2022 May 26;13:894163. doi: 10.3389/fimmu.2022.894163. eCollection 2022. Front Immunol. 2022. PMID: 35693823 Free PMC article.
-
Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease.Front Immunol. 2021 Jun 25;12:695815. doi: 10.3389/fimmu.2021.695815. eCollection 2021. Front Immunol. 2021. PMID: 34305932 Free PMC article. Review.
-
G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.Pharmacol Rev. 2020 Jan;72(1):1-49. doi: 10.1124/pr.118.016899. Pharmacol Rev. 2020. PMID: 31767622 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous
